AF
NUVL

Amalgamated Financial’s Nuvalent NUVL Stock Holding History

Amalgamated Financial’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$22K Buy
+1,560
New +$22.7K ﹤0.01% 2718

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Amalgamated Financial's NUVL Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Nuvalent (NUVL) in Q1 2022: 1,560 shares worth $22K. The stake represents ﹤0.01% of the portfolio and ranks #2718 among its holdings.

55 funds tracked by Wall St. Rank hold NUVL as of Q1 2022.

  • Amalgamated Financial held 1,560 shares of Nuvalent worth $22K as of Q1 2022.
  • Nuvalent was a new Amalgamated Financial position in Q1 2022.
  • Nuvalent made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2718 holding.
  • 55 funds tracked by Wall St. Rank held Nuvalent as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.